When.com Web Search

  1. Ads

    related to: alternative medicine for ovarian cancer side effects of chemotherapy for breast cancer

Search results

  1. Results From The WOW.Com Content Network
  2. Olaparib - Wikipedia

    en.wikipedia.org/wiki/Olaparib

    In January 2018, olaparib was approved in the United States for the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any ...

  3. Alternative cancer treatments - Wikipedia

    en.wikipedia.org/wiki/Alternative_cancer_treatments

    Breast cancer patients choosing alternative medicine were 5.68 times more likely to die within five years of diagnosis. [10] Although they are more likely to die than non-users, some users of alternative treatments feel a greater sense of control over their destinies and report less anxiety and depression. [24]

  4. Antihormone therapy - Wikipedia

    en.wikipedia.org/wiki/Antihormone_therapy

    Ovarian suppression is known to slow the growth of hormone receptor-positive breast cancer in premenopausal women [13] and can also help preserve fertility during chemotherapy. [14] Ovarian suppression through drugs temporarily shuts down the ovaries preventing the production of oestrogen, thus slowing the rate of growth of hormone receptor ...

  5. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  6. PARP inhibitor - Wikipedia

    en.wikipedia.org/wiki/PARP_inhibitor

    Side effects of PARP inhibitor treatment for cancer may include neutropenia, and a risk of anaemia. [25] People who take this medication also commonly report fatigue. [ 25 ] The toxicity profile of PARP inhibitors when treating cancer has not been found to be more serious than chemotherapy agents, however, further research is needed to ...

  7. Women with uncommon form of ovarian cancer offered hope with ...

    www.aol.com/news/women-uncommon-form-ovarian...

    Experts hope treatment will change practice globally for people with no or few treatment options ... Lighter Side. Medicare. new; News. Science & Tech. Shopping. Sports. Weather ...

  1. Ads

    related to: alternative medicine for ovarian cancer side effects of chemotherapy for breast cancer